Fundamental dimension Equity attribute | HWMLeader $187.00▼-3.25% Cap $74.58BP/E 40.0x QuantScore53/100 | AIRIPeer $2.60▲+2.77% Cap $12.61MP/E -7.0x QuantScore51/100 | ATIPeer $182.67▼-3.49% Cap $24.87BP/E 45.0x QuantScore44/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
73/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 38/100 | 64/100 | 25/100 |
Health Piotroski, Altman Z, leverage & liquidity | 76/100 | 11/100 | 66/100 |
Growth Revenue / earnings growth & margins | 51/100 | 8/100 | 25/100 |
Sentiment Analyst ratings, targets & revisions | 80/100 | 100/100 | 66/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 40.0x | -7.0x | 45.0x |
Forward P/E (next FY) | 35.0x | -7.4x | 35.6x |
EV / EBITDA (TTM) | 28.5x | 10.3x | 26.2x |
Price / Sales | 8.2x | 0.3x | 4.5x |
Price / Free Cash Flow | 47.5x | -2.7x | 40.6x |
PEG ratio | 1.12 | -0.17 | 2.82 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 2 / 9 | 7 / 9 |
Altman Z-Score | 8.20 (Safe) | -0.54 (Distress) | 5.22 (Safe) |
Total debt / equity | 0.79 | 1.43 | 1.17 |
Quick ratio | 0.9x | 0.3x | 1.1x |
Interest coverage | 15.4x | -0.3x | 7.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +11.1% | -13.0% | +5.2% |
Net income growth YoY | +30.6% | +4.5% | +9.9% |
Gross margin (TTM) | 35.2% | 19.4% | 23.4% |
Operating margin (FY) | 24.8% | -0.7% | 13.8% |
FCF margin (FY) | 17.3% | -9.8% | 7.3% |
5. Trailing price performancePrice change over period |
1M return | -19.0% | +1.2% | -15.8% |
3M return | -35.7% | -4.4% | -20.7% |
6M return | -23.3% | -18.2% | +1.7% |
Year to date | -9.3% | -15.3% | +36.7% |
1Y return | -6.4% | -22.2% | +75.8% |
3Y return | +327.3% | -16.1% | +329.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $105.41 -43.6% premium | $6.09 +134.3% upside | $36.45 -80.0% premium |
Wall Street consensus target | $328.10 +75.5% · range $290.00–$370.00 | — — | $242.00 +32.5% · range $180.00–$275.00 |
Consensus stance | 84% Buy12% Hold4% Sell | 100% Buy0% Hold0% Sell | 68% Buy29% Hold3% Sell |